Otologic effects of topical mitomycin C: Phase I - Evaluation of ototoxicity

Otology and Neurotology

Volumn 26, Issue 2, 2005, Pages 140-144

  Babu, Seilesh C ^a,b   Kartush, Jack M ^a,b,c   Patni, Aftab ^a,b  

^a MICHIGAN EAR INSTITUTE   (United States)

^b PROVIDENCE HOSPITAL   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Granulation tissue; Mitomycin C; Ototoxicity; Scarring

Indexed keywords

GELFOAM; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY THRESHOLD; CONCENTRATION RESPONSE; CONDUCTION DEAFNESS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SAFETY; EARDRUM PERFORATION; EVOKED BRAIN STEM AUDITORY RESPONSE; GRANULATION TISSUE; NONHUMAN; OTOTOXICITY; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RAT; SCAR FORMATION; SURGICAL TECHNIQUE; WOUND HEALING;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AUDITORY THRESHOLD; CICATRIX; DOSE-RESPONSE RELATIONSHIP, DRUG; EAR, MIDDLE; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GELATIN SPONGE, ABSORBABLE; GENTAMICINS; HEARING LOSS, CONDUCTIVE; MASTOID; MITOMYCIN; RATS; RATS, SPRAGUE-DAWLEY; WOUND HEALING;

EID: 15744398418     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200503000-00002     Document Type: Article

References (18)

1. Cankaya H, Egeli E, Kuntsal L, Ozbek H, Icli M. Effects of topical mitomycin on inner ear: a light and electron microscopic study. Tohoku Exp Med 2002;197:81-6.
2. Khaw PT, Doyle JW, Sherwood MB, et al. Prolonged localized tissue effects from 5 minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol 1993;111:263-7.
3. Lee DA, Lee TC, Cortes AE, Kitada S. Effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast attachment and proliferation. Invest Ophthalmol Vis Sci 1990;31:2136-44.
4. Ingrams DR, Volk MS, Biesman BS, et al. Sinus surgery: does mitomycin C reduce stenosis? Laryngoscope 1998;108:883-6.
5. Simman R, Alani H, Williams F. Effect of mitomycin C on keloid fibroblasts: an in vitro study. Ann Plast Surg 2003;50:71-6.
6. Chung JH, Cosenza MJ, Rahbar R, Metson RB. Mitomycin C for the prevention of adhesion formation after endoscopic sinus surgery: a randomized, controlled study. Otolaryngol Head Neck Surg 2002; 126:468-74.
7. Ingrams DR, Volk MS, Biesman BS, et al. Sinus surgery: does mitomycin C reduce stenosis? Laryngoscope 1998;108:883-6.
8. Yamamoto T, Varani J, Soong HK, et al. Effects of 5 fluorouracil and mitomycin C on cultured rat fibroblasts. Ophthalmology 1990;97: 1204-10.
9. Chen CW, Huang HT, Blair JS, et al. Trabeculectomy with simultaneous topical application of mitomycin C in refractory glaucoma. J Ocul Pharmacol 1990;6:175-82.
10. Rahbar R, Shapshay S, Healy G. Mitomycin: effects on laryngeal and tracheal stenosis, benefits and complications. Ann Otol Laryngol 2001;110:1-6.
11. Jassir D, Buchman CA, Gomez-Marin O. Safety and efficacy of topical mitomycin C in myringotomy patency. Otolaryngol Head Neck Surg 2001;124:368-73.
12. Huang TS. Topical mitomycin C and cephalosporin in endolymphatic sac surgery. Laryngoscope 2002;112:243-7.
13. Banthia V, Selesnick S. Mitomycin-C in the postsurgical ear canal. Otolaryngol Head Neck Surg 2003;128:882-6.
14. Becvarovski Z, Bojrab DI, Michaelides EM, et al. Round window gentamicin absorption: an in vivo human model. Laryngoscope 2002;112:1610-3.
15. Plontke S, Wood A, Salt A. Analysis of gentamicin kinetics in fluids of the inner ear with round window administration. Otol Neurotol 2002;23:967-74.
16. Gerber, Mark E. The evolving role of ototopical therapy. Curr Opin Otolaryngol Head Neck Surg 2000;8:454-7.
17. Wong DH, Rutka JA. Do aminoglycoside otic preparations cause ototoxicity in the presence of tympanic membrane perforations. Otolaryngol Head Neck Surg 1997;116:404-10.
18. Hui Y, Park A, Crysdale WS, et al. Ototoxicity from ototopical aminoglycosides. J Otolaryngol 1997;26:53-6.